PFE Feb 2023 80.000 put
| Previous Close | 23.45 |
| Open | 23.45 |
| Bid | 25.70 |
| Ask | 28.30 |
| Strike | 80.00 |
| Expire Date | 2023-02-17 |
| Day's Range | 23.45 - 23.45 |
| Contract Range | N/A |
| Volume | |
| Open Interest | 1 |
- Reuters
German health minister in move to boost use of COVID treatment Paxlovid
Germany's health minister said on Sunday he will push for more prescriptions of Pfizer's oral COVID-19 antiviral treatment Paxlovid by family doctors to reduce severe cases of the disease. "A system involving family doctors will be prepared to administer this far too rarely-used COVID life saver more routinely," he wrote https://twitter.com/Karl_Lauterbach/status/1543582226788634624 on Twitter on Sunday, adding that sufficient stockpiles were available. In his tweet, Lauterbach mentioned trial results that the oral treatment course can cut the risk of hospitalisation in the elderly by 90%, when taken early after infection.
- Yahoo Finance
How mRNA tech blew open the door of UPS's cold chain logistics business
mRNA blew open the door for more cold chain logistics business, helping UPS grow at twice the pace it had previously anticipated.
- Zacks
Pfizer (PFE) Seeks FDA Nod for Its Oral Antiviral COVID Pill
Pfizer (PFE) submits NDA to the FDA seeking approval for using its oral antiviral COVID pill in vaccinated and unvaccinated patients at a high risk of developing severe COVID-19 complications.
